| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $807,664 ) |
| | 2025 | 2025 | HELIGENICS, INC. | 10530 DISCOVERY DR | LAS VEGAS | NV | 89135-3039 | CLARK | USA | R44AI188872 | High Content Screening for Bifunctional Chimera Biologics | 000 | 1 | NIH | 12/30/2024 | $807,664 |
| | 2025 | 2023 | HELIGENICS, INC. | 10530 DISCOVERY DR | LAS VEGAS | NV | 89135-3039 | CLARK | USA | R43HG012537 | High-throughput functional analysis and clinical relevance of all possible variants of a gene | 000 | 1 | NIH | 3/5/2025 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $398,526 ) |
| | 2023 | 2023 | HELIGENICS INC | 833 LAS VEGAS BLVD N | LAS VEGAS | NV | 89101-2059 | CLARK | USA | R43HG012537 | High-throughput functional analysis and clinical relevance of all possible variants of a gene | 000 | 1 | NIH | 2/2/2023 | $398,526 |
|
|
